← FDA DRUG APPROVALS

FDA ANDA · ANDA077308

KETOROLAC TROMETHAMINE

Sponsor: APOTEX

APPLICATION
ANDA077308
TYPE
ANDA
ORIGINAL APPROVAL
2009-11-05
LATEST ACTION
2017-12-27
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

KETOROLAC TROMETHAMINEDiscontinued
KETOROLAC TROMETHAMINE 0.4% · SOLUTION/DROPS · OPHTHALMIC

Approval history

2017-12-27Labeling · Supplement 7 · standardAP
2015-12-11Labeling · Supplement 5 · standardAP
2013-03-28Manufacturing (CMC) · Supplement 1AP
2009-11-05OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →